Skip Nav Destination
Issues
1 February 2019
-
Cover Image
Cover Image
ABOUT THE COVERClose Modal
In this issue (beginning on page 370), Mooneyham and colleagues demonstrate that UNC-45A is a novel microtubule-associated protein that antagonizes the effect of paclitaxel in ovarian cancer cells, leading to chemoresistance. The immunofluorescent cover image shows strong co-localization between UNC-45A (red) and alpha tubulin (green) in synchronized metaphase HeLa cells. This finding was key in the later identification of UNC-45A as a novel microtubule-associated protein that functions to destabilize microtubules and confer paclitaxel resistance. Together, this study reveals UNC-45A as a promising biomarker and molecular target for paclitaxel-resistant human cancers.
Cover image by Mooneyham not featured in article. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1541-7786
EISSN 1557-3125
Highlights
Review
Rapid Impact
Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer
Yuqing Zhang; Amanda Kirane; Huocong Huang; Noah B. Sorrelle; Francis J. Burrows; Michael T. Dellinger; Rolf A. Brekken
Cell Cycle and Senescence
UNC-45A Is a Novel Microtubule-Associated Protein and Regulator of Paclitaxel Sensitivity in Ovarian Cancer Cells
Ashley Mooneyham; Yoshie Iizuka; Qing Yang; Courtney Coombes; Mark McClellan; Vijayalakshmi Shridhar; Edith Emmings; Mihir Shetty; Liqiang Chen; Teng Ai; Joyce Meints; Michael K. Lee; Melissa Gardner; Martina Bazzaro
Cell Death and Survival
Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells
Laure Malric; Sylvie Monferran; Caroline Delmas; Florent Arnauduc; Perrine Dahan; Sabrina Boyrie; Pauline Deshors; Vincent Lubrano; Dina Ferreira Da Mota; Julia Gilhodes; Thomas Filleron; Aurore Siegfried; Solène Evrard; Aline Kowalski-Chauvel; Elizabeth Cohen-Jonathan Moyal; Christine Toulas; Anthony Lemarié
Author Choice
PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow
Todd A. Hopkins; William B. Ainsworth; Paul A. Ellis; Cherrie K. Donawho; Enrico L. DiGiammarino; Sanjay C. Panchal; Vivek C. Abraham; Mikkel A. Algire; Yan Shi; Amanda M. Olson; Eric F. Johnson; Julie L. Wilsbacher; David Maag
DNA Damage and Repair
Genomics
Author Choice
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Habiba Elfandy; Joshua Armenia; Filippo Pederzoli; Eli Pullman; Nelma Pertega-Gomes; Nikolaus Schultz; Kartik Viswanathan; Aram Vosoughi; Mirjam Blattner; Konrad H. Stopsack; Giorgia Zadra; Kathryn L. Penney; Juan Miguel Mosquera; Svitlana Tyekucheva; Lorelei A. Mucci; Christopher Barbieri; Massimo Loda
Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer
Ahmed Basudan; Nolan Priedigkeit; Ryan J. Hartmaier; Ethan S. Sokol; Amir Bahreini; Rebecca J. Watters; Michelle M. Boisen; Rohit Bhargava; Kurt R. Weiss; Maria M. Karsten; Carsten Denkert; Jens-Uwe Blohmer; Jose P. Leone; Ronald L. Hamilton; Adam M. Brufsky; Esther Elishaev; Peter C. Lucas; Adrian V. Lee; Steffi Oesterreich
High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer
Simon Garinet; Géraldine Pignot; Sophie Vacher; Constance Le Goux; Anne Schnitzler; Walid Chemlali; Nanor Sirab; Nicolas Barry Delongchamps; Marc Zerbib; Mathilde Sibony; Yves Allory; Diane Damotte; Ivan Bieche
Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells
Kei Namba; Kazuhiko Shien; Yuta Takahashi; Hidejiro Torigoe; Hiroki Sato; Takahiro Yoshioka; Tatsuaki Takeda; Eisuke Kurihara; Yusuke Ogoshi; Hiromasa Yamamoto; Junichi Soh; Shuta Tomida; Shinichi Toyooka
Oncogenes and Tumor Suppressors
Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma
Eric P. Rahrmann; Natalie K. Wolf; George M. Otto; Lynn Heltemes-Harris; Laura B. Ramsey; Jingmin Shu; Rebecca S. LaRue; Michael A. Linden; Susan K. Rathe; Timothy K. Starr; Michael A. Farrar; Branden S. Moriarity; David A. Largaespada
PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas
Kristen S. Hill; Evan R. Roberts; Xue Wang; Ellen Marin; Taeeun D. Park; Sorany Son; Yuan Ren; Bin Fang; Sean Yoder; Sungjune Kim; Lixin Wan; Amod A. Sarnaik; John M. Koomen; Jane L. Messina; Jamie K. Teer; Youngchul Kim; Jie Wu; Charles E. Chalfant; Minjung Kim
Signal Transduction
Author Choice
Epigenetic Silencing of THY1 Tracks the Acquisition of the Notch1–EGFR Signaling in a Xenograft Model of CD44+/CD24low/CD90+ Myoepithelial Cells
Micaela Montanari; Maria Rita Carbone; Luigi Coppola; Mario Giuliano; Grazia Arpino; Rossella Lauria; Agostina Nardone; Felicia Leccia; Meghana V. Trivedi; Corrado Garbi; Roberto Bianco; Enrico V. Avvedimento; Sabino De Placido; Bianca Maria Veneziani
Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance
Ida Aronchik; Yumin Dai; Matt Labenski; Carmen Barnes; Terri Jones; Lixin Qiao; Lisa Beebe; Mehnaz Malek; Winfried Elis; Tao Shi; Konstantinos Mavrommatis; Gordon L. Bray; Ellen H. Filvaroff
Advertisement